CARTER DENISE P. (Chief Operating Officer) purchased 1179.7% of their position (555.56K shares) of QUOIN PHARMACEUTICALS, LTD. on the open market
Open‑market purchase worth $250.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/27/2024ACC: 0001104659-24-132190
DirectorOfficer· Chief Operating Officer
Since Feb 2026
+1.67M
Net shares
Net buyer
$250.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
1.67M acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+555.56K
Price / share
$0.45
Trade value
$250K
% of position
1179.7%
12/23/2024
47.09K→602.65K
Total
Net shares
+555.56K
Net value
$250K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 12/23/2024 | P · Purchase | +555.56K | $0.45 | $250K | 1179.7% | 47.09K | 602.65K |
| Total | +555.56K | $250K | ||||||
Derivative Transactions2
Series F Warrants (right to buy)
Direct
Converts to
ADS
555.56K shares
Shares
+555.56K
Strike price
0.45
Held after
555.56K
Exercisable
—
12/23/2024
Series G Warrants (right to buy)
Direct
Converts to
ADS
555.56K shares
Shares
+555.56K
Strike price
0.45
Held after
555.56K
Exercisable
—
12/23/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series F Warrants (right to buy) Direct | ADS555.56K shares | 12/23/2024 | P · Purchase | +555.56K | 0.45 | — | 555.56K |
| Series G Warrants (right to buy) Direct | ADS555.56K shares | 12/23/2024 | P · Purchase | +555.56K | 0.45 | — | 555.56K |